BioMarin Pharmaceutical (1BMRN) Drug Pipeline
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Biomarin Pharmaceutical Inc. (IT:1BMRN) have in its pipeline
BioMarin Pharmaceutical IT:1BMRN is currently developing the following drugs: Bmn 351, Methotrexate, Pegvaliase, Mtx, Palynziq, Inz-701, Bmn 333, Vosoritide Injection [Voxzogo], Vosoritide, Rdd To Palynziq, Bmn 349, Human Growth Hormone, Vosoritide Injection, Valoctocogene Roxaparvovec, Control Arm, Inz-701, Pegvaliase, Diet Only, Bmn 307, Active Bmn 111: Subcutaneous Injection Of Recommended Dose Of Bmn 111 Based On Weight-Band Dosing Once Daily., Bmn 111, Bmn 190 Recombinant Human Tripeptidyl Peptidase-1, Intracerebroventricular Access Device. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
